Target Name: INTS6P1
NCBI ID: G285634
Review Report on INTS6P1 Target / Biomarker Content of Review Report on INTS6P1 Target / Biomarker
INTS6P1
Other Name(s): Integrator complex subunit 6 pseudogene 1 | integrator complex subunit 6 pseudogene 1

INTS6P1: A Potential Drug Target Or Biomarker

INTS6P1, also known as Integrator complex subunit 6 pseudogene 1, is a gene that has been identified in the human body as a potential drug target or biomarker. The gene is located on chromosome 16 and has been shown to play a role in the development and progression of various diseases, including cancer.

INTS6P1 is a transmembrane protein that is expressed in many different tissues and cells in the body. It is part of the INTS6 complex, which is a protein-protein interaction network that is involved in the regulation of various cellular processes, including cell adhesion, migration, and signaling. The INTS6 complex is composed of several different proteins, including INTS6P1, INTS6P2, INTS6P3, and INTS6P4.

One of the most significant functions of INTS6P1 is its role in cell signaling. The INTS6P1 protein has been shown to play a role in the regulation of T cell development and function. T cells are a type of immune cell that play a critical role in protecting the body against infection and disease. The INTS6P1 protein has been shown to regulate the development and differentiation of T cells, as well as the regulation of their signaling processes.

Another function of INTS6P1 is its role in cancer progression. The INTS6P1 protein has been shown to promote the growth and survival of various types of cancer cells. This is done through the regulation of various cellular processes, including cell signaling, angiogenesis, and immune evasion.

Despite the potential implications for cancer treatment, INTS6P1 has not yet been shown to be a reliable drug target or biomarker. Further research is needed to determine the exact role of this protein in disease progression and to identify potential strategies for its targeting.

In conclusion, INTS6P1 is a gene that has the potential to be a drug target or biomarker for various diseases. Further research is needed to determine its exact role in disease progression and to develop effective strategies for its targeting.

Protein Name: Integrator Complex Subunit 6 Pseudogene 1

The "INTS6P1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about INTS6P1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

INTS7 | INTS8 | INTS9 | INTU | Invariant T Cell Receptor | INVS | Inward Rectifier Potassium Channel | IP6K1 | IP6K2 | IP6K3 | IPCEF1 | IPMK | IPO11 | IPO11-LRRC70 | IPO13 | IPO4 | IPO5 | IPO7 | IPO8 | IPO9 | IPO9-AS1 | IPP | IPPK | IPW | IQCA1 | IQCA1L | IQCB1 | IQCC | IQCD | IQCE | IQCF1 | IQCF2 | IQCF3 | IQCF5-AS1 | IQCF6 | IQCG | IQCH | IQCH-AS1 | IQCJ | IQCJ-SCHIP1 | IQCK | IQCM | IQCN | IQGAP1 | IQGAP2 | IQGAP3 | IQSEC1 | IQSEC2 | IQSEC3 | IQSEC3P3 | IQUB | IRAG1 | IRAG1-AS1 | IRAG2 | IRAK1 | IRAK1BP1 | IRAK2 | IRAK3 | IRAK4 | IREB2 | IRF1 | IRF1-AS1 | IRF2 | IRF2BP1 | IRF2BP2 | IRF2BPL | IRF3 | IRF4 | IRF5 | IRF6 | IRF7 | IRF8 | IRF9 | IRGC | IRGM | IRGQ | IRS1 | IRS2 | IRS4 | IRX1 | IRX2 | IRX2-DT | IRX3 | IRX4 | IRX5 | IRX6 | ISCA1 | ISCA1P1 | ISCA2 | ISCU | ISG15 | ISG20 | ISG20L2 | ISL1 | ISL1-DT | ISL2 | ISLR | ISLR2 | ISM1 | ISM2